News
CHMP recommends Sanofi and AstraZeneca’s Beyfortus to treat respiratory syncytial virus
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Beyfortus for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants.